BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14620504)

  • 1. Reduced phagocytosis of colloidal carriers using soluble CD47.
    Hsu YC; Acuña M; Tahara SM; Peng CA
    Pharm Res; 2003 Oct; 20(10):1539-42. PubMed ID: 14620504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.
    Oldenborg PA; Gresham HD; Lindberg FP
    J Exp Med; 2001 Apr; 193(7):855-62. PubMed ID: 11283158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1.
    Tada K; Tanaka M; Hanayama R; Miwa K; Shinohara A; Iwamatsu A; Nagata S
    J Immunol; 2003 Dec; 171(11):5718-26. PubMed ID: 14634079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.
    Okazawa H; Motegi S; Ohyama N; Ohnishi H; Tomizawa T; Kaneko Y; Oldenborg PA; Ishikawa O; Matozaki T
    J Immunol; 2005 Feb; 174(4):2004-11. PubMed ID: 15699129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
    Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
    Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of B16 melanoma cells to CD47-induced negative regulation of motility as a result of aberrant N-glycosylation of SHPS-1.
    Ogura T; Noguchi T; Murai-Takebe R; Hosooka T; Honma N; Kasuga M
    J Biol Chem; 2004 Apr; 279(14):13711-20. PubMed ID: 14739297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
    Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
    J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD47 as a marker of self on red blood cells.
    Oldenborg PA; Zheleznyak A; Fang YF; Lagenaur CF; Gresham HD; Lindberg FP
    Science; 2000 Jun; 288(5473):2051-4. PubMed ID: 10856220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.
    Olsson M; Bruhns P; Frazier WA; Ravetch JV; Oldenborg PA
    Blood; 2005 May; 105(9):3577-82. PubMed ID: 15665111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells.
    Seiffert M; Brossart P; Cant C; Cella M; Colonna M; Brugger W; Kanz L; Ullrich A; Bühring HJ
    Blood; 2001 May; 97(9):2741-9. PubMed ID: 11313266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
    Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new way to keep immune cells in check.
    Hagmann M
    Science; 2000 Jun; 288(5473):1945-6. PubMed ID: 10877706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation.
    Han X; Sterling H; Chen Y; Saginario C; Brown EJ; Frazier WA; Lindberg FP; Vignery A
    J Biol Chem; 2000 Dec; 275(48):37984-92. PubMed ID: 10964914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
    Liu Y; O'Connor MB; Mandell KJ; Zen K; Ullrich A; Bühring HJ; Parkos CA
    J Immunol; 2004 Feb; 172(4):2578-85. PubMed ID: 14764731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
    Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
    J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD47 in erythroid cells and in autoimmunity.
    Oldenborg PA
    Leuk Lymphoma; 2004 Jul; 45(7):1319-27. PubMed ID: 15359629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
    Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
    J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.
    Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS
    Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
    Petrova PS; Viller NN; Wong M; Pang X; Lin GH; Dodge K; Chai V; Chen H; Lee V; House V; Vigo NT; Jin D; Mutukura T; Charbonneau M; Truong T; Viau S; Johnson LD; Linderoth E; Sievers EL; Maleki Vareki S; Figueredo R; Pampillo M; Koropatnick J; Trudel S; Mbong N; Jin L; Wang JC; Uger RA
    Clin Cancer Res; 2017 Feb; 23(4):1068-1079. PubMed ID: 27856600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.